Cancer-Related Dictionary

Gliosarcoma is a rare and aggressive type of brain tumor that contains both glial and sarcomatous components. It is a variant of glioblastoma and typically occurs in adults, often presenting with symptoms such as headaches, seizures, and neurological deficits.

A grading system is a method used by healthcare professionals to classify the severity or stage of a disease, particularly cancer, based on certain criteria such as cell appearance and behavior. This helps in determining the appropriate treatment plan and predicting the disease outcome.

A growth factor receptor is a protein found on the surface of certain cells that binds to specific growth factors. These receptors play a crucial role in regulating cell growth, division, and survival by transmitting signals from outside the cell to the inside.

A haploidentical donor is a family member whose tissue type matches exactly half of the recipient's human leukocyte antigen (HLA) markers, used often in bone marrow transplants when a fully matched donor is not available.

Hedgehog pathway inhibitors are a class of drugs that block the Hedgehog signaling pathway, which is involved in cell growth and development. These inhibitors are primarily used in treating certain types of cancer where this pathway is abnormally activated.

Heterogeneity refers to the presence of diverse and distinct characteristics within a particular group or system. In a medical context, it often describes the differences in cells, tissues, or diseases, indicating variability in genetic, molecular, or clinical features.

High-throughput sequencing, also known as next-generation sequencing, is a modern DNA sequencing technology that enables rapid sequencing of large amounts of DNA. It allows scientists to sequence entire genomes quickly and efficiently, making it an essential tool in genomics research and personalized medicine.

Homologous recombination deficiency (HRD) is a condition where cells lose the ability to effectively repair DNA double-strand breaks using the homologous recombination repair pathway. This deficiency can lead to genomic instability and is often associated with certain types of cancer, such as breast and ovarian cancers.

Immunogenicity refers to the ability of a substance, such as a vaccine or therapeutic protein, to provoke an immune response in the body. This response can be beneficial, as in the case of vaccines, or undesirable, as it can lead to adverse reactions or reduce the effectiveness of treatments.

Indolent lymphoma is a type of cancer that affects the lymphatic system. It is characterized by slow growth and progression, which means it often takes years to become serious. Despite its slow nature, it can still require treatment and monitoring.

Intrathecal chemotherapy is a type of cancer treatment where chemotherapy drugs are injected directly into the cerebrospinal fluid surrounding the brain and spinal cord. This method is used to target cancer cells in the central nervous system.

Long-term follow-up (LTFU) care is important for childhood, adolescent, and young adult cancer survivors due to their high risk of late effects. LTFU includes prevention, early detection, and management of late effects to improve the quality of survivorship. Additionally, follow-up provides an opportunity to offer age-appropriate information about disease, treatment, and a healthy lifestyle, as well as practical advice about insurance, education or work, and psychosocial support. Current LTFU guidelines for mental health problems note that healthcare providers and survivors of childhood, adolescent and young adult cancer should be aware that survivors are at risk for mental disorder symptoms. For all survivors, surveillance is recommended for: Depression and mood disorders Anxiety Psychological distress Post-traumatic stress Behavioral problems Suicidal ideation The guidelines recommend mental health surveillance for patients throughout treatment for cancer and for survivors to begin at the first follow-up visit and continue throughout the lifespan. Mental health surveillance is recommended for all survivors at every follow-up visit (or at general medical check-ups).

A low-grade glioma is a type of brain tumor that originates from glial cells, which support nerve cells. These tumors are considered slow-growing and less aggressive compared to high-grade gliomas, but they can still cause significant health issues depending on their size and location in the brain.

Lymphatic mapping is a medical procedure used to identify the lymph nodes that are the first to receive drainage from a tumor. These nodes, called sentinel lymph nodes, are examined to determine if cancer has spread.

Lymphomatoid papulosis is a rare skin disorder characterized by recurring, self-healing skin lesions that resemble lymphoma but are typically benign. These lesions can appear as red-brown bumps or nodules on the skin and may last for weeks or months before resolving on their own.

"Malignant" is an adjective commonly used in medical contexts, referring to a severe and progressively worsening disease, often cancer. It denotes conditions characterized by uncontrolled growth, induction of damage to surrounding tissues, and the potential to spread to other body organs, causing serious health risks and possibly death.

Marginal zone lymphoma is a type of slow-growing non-Hodgkin lymphoma that originates in the marginal zone of lymphoid tissue, which is part of the immune system. It often affects the spleen, lymph nodes, or mucosa-associated lymphoid tissue (MALT) and is characterized by the abnormal proliferation of B-cells.

Mediastinal lymphoma is a type of cancer that occurs in the lymph nodes located in the mediastinum, the central part of the chest between the lungs. It involves the abnormal growth of lymphocytes, which are a type of white blood cell, and can affect the body's immune system.

Melanoma in situ is an early form of skin cancer where the malignant cells are confined to the outermost layer of the skin, known as the epidermis. It is the earliest stage of melanoma and is highly treatable when detected early.

Molecular imaging is a type of medical imaging that provides detailed pictures of what is happening inside the body at the molecular and cellular level. This technique is used to visualize the processes in the body, such as how a disease progresses or how a treatment is working.

Non-invasive cancer, also known as in situ cancer, is a type of cancer that has not spread beyond the layer of cells where it initially developed. It remains confined to the place of origin and has not invaded neighboring tissues or metastasized to other parts of the body.

An oncogenic virus is a type of virus that can cause cancer by altering the genetic material of the host cells it infects. These viruses can disrupt normal cell regulation and lead to uncontrolled cell growth.

An ovarian germ cell tumor is a type of cancer that originates from the cells in the ovaries responsible for producing eggs. These tumors are rare and primarily affect young women and adolescents. While most ovarian germ cell tumors are benign, some can be malignant and require medical treatment.

Current ovarian reserve tests include hormonal markers and ultrasonographic markers.  Hormonal markers: are determined in the blood after a blood sample is taken. Suitable markers are FSH (follicle-stimulating hormone), estradiol, inhibin-B, and antimullerian hormone (AMH).  The measurement of FSH levels at 2 or 3 days after the onset of full menstrual flow has been used as a marker of ovarian reserve since the 1980s, based on its association with reproductive outcome. Elevated FSH values are associated with but not always predictive of poor ovarian response and failure to conceive. Estradiol is the natural estrogen of the woman and is responsible for the expression of the female secondary sexual characteristics. It is produced by granulosa cells of the ovarian follicles. Estradiol levels are commonly assessed during the early follicular phase and high levels indicate normal functioning. Inhibin is a peptide hormone with 2 subunits (Alpha and Beta). Inhibin-B is produced by granulosa cells of ovarian follicles and its levels vary during the menstrual cycle. Concentrations of inhibin-B decrease with age and during premature ovarian failure. AMH is a proteohormone and is produced by granulosa cells of the follicles. AMH shows little cycle fluctuation and correlates negatively with the progression of follicle loss and with a woman's age: the higher the AMH, the higher the follicle count.  Ultrasonographic markers: include the antral follicle count (AFC) and the measurement of ovarian volume, both assessed through ultrasound of the ovaries. The AFC describes the number of antral follicles in the ovaries measuring between 2–10mm. The greatest advantage of ultrasonographic markers of ovarian reserve is their non-invasiveness. Both markers exhibit an age-related decline.

Palliative chemotherapy is a type of cancer treatment aimed at relieving symptoms and improving quality of life for patients with advanced cancer. It is not intended to cure the cancer but to manage pain and other symptoms.

Peritoneal carcinomatosis is a condition where cancer cells spread to the peritoneum, the lining of the abdominal cavity. This often occurs in advanced stages of abdominal cancers such as ovarian, gastric, or colorectal cancer, leading to symptoms like abdominal pain, bloating, and weight loss.

Pleomorphic adenoma is a benign tumor that typically occurs in the salivary glands, most commonly in the parotid gland. It is characterized by a mix of different cell types and structures, hence the name 'pleomorphic.' While generally non-cancerous, it can become malignant if not treated.

"Preclinical" refers to the phase of research conducted before a new drug or treatment is tested on humans. This stage involves laboratory experiments using cell cultures and animal testing to determine the efficacy, potential side effects, and optimal dosage. It is a fundamental step in drug development and policy-making in healthcare.

Prognostic factors are specific characteristics that help predict the likely outcome or course of a disease in a patient. These factors can include age, stage of disease, and specific biological markers, and they assist healthcare providers in determining the best treatment approach.

Protein biomarkers are specific proteins found in the body that can be measured and used to indicate a biological state, such as the presence of a disease or condition. They help in diagnosing diseases, predicting disease progression, and monitoring treatment responses.

Pulmonary metastases refer to cancer cells that have spread from a primary tumor located in another part of the body to the lungs. This process is known as metastasis, and it indicates that the cancer is at an advanced stage.

Radiation fibrosis syndrome is a condition that occurs when healthy tissue becomes scarred and stiff after exposure to radiation therapy, commonly used in cancer treatment. This can lead to a range of symptoms depending on the area affected, including pain, restricted movement, and functional impairments.

Radiation necrosis is a condition where healthy tissue is damaged and dies as a result of exposure to radiation therapy, typically used in cancer treatment. This can lead to symptoms such as swelling, neurological deficits, and other complications depending on the area affected.

Rare cancers are types of cancer that occur infrequently, affecting a small percentage of the population. They can be challenging to diagnose and treat due to limited research and awareness.

Refractory cancer is a type of cancer that does not respond to treatment. It may continue to grow or spread despite therapy, making it challenging to manage.

Renal angiomyolipoma is a benign tumor of the kidney composed of blood vessels, muscle, and fat. It is usually non-cancerous and often goes undetected unless it causes symptoms or complications.

Residual disease refers to the small amount of cancer cells that may remain in the body after treatment, which can lead to a recurrence if not effectively managed.

Retroperitoneal sarcoma is a rare type of cancer that develops in the connective tissues located in the retroperitoneal space, an area in the back of the abdomen behind the peritoneum, which is the lining of the abdominal cavity. These tumors can grow quite large before causing symptoms, as they have space to expand in the retroperitoneal area.

Risk stratification is a process used in healthcare to categorize patients based on their risk of developing certain diseases or complications. It helps doctors prioritize care and tailor treatments based on the level of risk.

Sarcomatoid carcinoma is a rare type of cancer that exhibits both carcinoma and sarcoma characteristics. It is an aggressive tumor that can occur in various organs and tissues, often presenting challenges in diagnosis and treatment due to its mixed cellular components.

Secondary cancer, also known as metastatic cancer, occurs when cancer cells spread from the original (primary) site to another part of the body. This process involves the movement of cancer cells through the bloodstream or lymphatic system, leading to the formation of new tumors in other organs or tissues. Secondary cancers retain the name of the primary cancer type, even though they appear in a different location.

Secondary malignancies are new cancers that occur in a person who has previously been diagnosed with cancer. These are not recurrences of the original cancer but entirely new types of cancer that develop as a result of the initial cancer treatment, genetic predisposition, or other risk factors.

A sentinel lymph node biopsy is a surgical procedure used to determine if cancer has spread beyond a primary tumor into the lymphatic system. It involves identifying, removing, and examining the sentinel lymph nodes, which are the first nodes to which cancer cells are likely to spread from a primary tumor.

Sentinel node mapping is a medical procedure used to identify the first lymph node, known as the sentinel node, that cancer cells are most likely to spread to from a primary tumor. This technique helps doctors determine the extent of cancer spread and plan appropriate treatment.

Serous carcinoma is a type of cancer that originates in the epithelial cells lining certain organs, most commonly the ovaries, fallopian tubes, and the peritoneum. It is characterized by the production of a thin, watery fluid and is known for its aggressive nature and rapid spread.

Sessile serrated lesions are a type of growth found in the colon that can potentially develop into cancer. They are characterized by a flat, broad base and a saw-tooth appearance under a microscope. These lesions are considered precancerous and are often detected during routine colonoscopies.

Small molecule inhibitors are a type of medication designed to block specific enzymes or proteins in cells that contribute to disease processes, such as cancer. These drugs are typically small enough to enter cells easily and interfere with the function of target molecules, helping to slow or stop the progression of diseases.

Spindle cell carcinoma is a rare type of cancer characterized by spindle-shaped cells that can appear in various parts of the body, often resembling sarcomas due to their shape. It typically occurs in the skin or soft tissues and can be aggressive, requiring prompt medical attention.

Splenic lymphoma is a type of cancer that originates in the lymphatic tissue of the spleen, a vital organ involved in filtering blood and supporting the immune system. It is characterized by the uncontrolled growth of lymphocytes, a type of white blood cell.

Sporadic cancer refers to cancer that occurs by chance and is not associated with inherited genetic mutations. Most cancers are sporadic, meaning they arise from genetic changes acquired during a person's lifetime due to environmental factors or random cell mutations.